← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2016Last known activity
Jan 31, 2026
Timeline
1840s
- Jun 1, 1848
Teikoku Seiyaku Co., Ltd.— Founded
Drugs by trial phase (2 distinct, 9 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (17)
- NCT07307794Lead sponsorPhase 1Jan 31, 2026
- NCT07307794OfficialPhase 1Jan 31, 2026
- NCT06866613OfficialPhase 3Mar 31, 2025
- NCT06866613Lead sponsorPhase 3Mar 31, 2025
- NCT06870422Lead sponsorPhase 1Feb 28, 2025
- NCT06870422OfficialPhase 1Feb 28, 2025
- NCT06871046OfficialPhase 3Feb 20, 2025
- NCT06871046Lead sponsorPhase 3Feb 20, 2025
- NCT06823284Lead sponsorPhase 1Jan 21, 2025
- NCT06823284OfficialPhase 1Jan 21, 2025
- NCT06042192Lead sponsorPhase 1Sep 18, 2023
- NCT06042192Study chairPhase 1Sep 18, 2023
- NCT06042192OfficialPhase 1Sep 18, 2023
- NCT04908748Study chairPhase 2May 20, 2021
- NCT04908748Lead sponsorPhase 2May 20, 2021
Details
- Founded
- Higashikagawa, JP Jun 1, 1848
- Last known activity
- Jan 31, 2026
Notes
Formulations - transdermal